BioHarvest Sciences (BHST)
NASDAQ:BHST
BHST Stock Chart & Stats
$11.28
--
Market closed
$11.28
--
Day’s Range― - ―
52-Week Range$4.10 - $12.80
Previous CloseN/A
VolumeN/A
Average Volume (3M)78.84K
Market Cap
$97.87M
Enterprise Value$84.06M
Total Cash (Recent Filing)$10.97M
Total Debt (Recent Filing)$19.84M
Price to Earnings (P/E)―
Beta0.70
Next Earnings
Mar 31, 2026EPS Estimate
-0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding22,654,290
10 Day Avg. Volume86,360
30 Day Avg. Volume78,844
Financial Highlights & Ratios
PEG Ratio0.55
Price to Book (P/B)75.25
Price to Sales (P/S)3.97
P/FCF Ratio-10.51
Enterprise Value/Market Cap0.86
Enterprise Value/Revenue2.57
Enterprise Value/Gross Profit4.34
Enterprise Value/Ebitda-18.24
Forecast
1Y Price Target
$10.00Price Target Upside-11.35% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-0.11
Revenue Forecast (FY)$47.47M
Bulls Say, Bears Say
Bulls Say
Balance Sheet And LiquidityCash balance of $11.4M combined with roughly $19.9M in gross proceeds strengthens liquidity and provides funding capacity for commercialization and CDMO scale-up.
Commercial Expansion And PartnershipsA new CDMO contract with Saffron Tech plus a commercial launch of a hydration product line and an influencer 'Health Pros' program support revenue diversification and DTC growth.
Revenue And ProfitabilityRevenue rose 39% to $9.1M while gross margin expanded to about 61%, signaling improving core profitability that could support a valuation re-rating.
Bears Say
Analyst Valuation RevisionAnalyst lowered the 12-month price target from $15 to $12, indicating reduced market expectations for near-term share performance.
Dilution RiskDilution from recent financing agreements increases share count, which can pressure earnings per share and per-share valuation.
Earnings Outlook UncertaintyLower analyst estimates highlight increased uncertainty around growth, creating risk of further downward revisions if commercialization and CDMO ramp fall short of expectations.
BioHarvest Sciences News
BHST FAQ
What was BioHarvest Sciences’s price range in the past 12 months?
BioHarvest Sciences lowest stock price was $4.10 and its highest was $12.80 in the past 12 months.
What is BioHarvest Sciences’s market cap?
BioHarvest Sciences’s market cap is $97.87M.
When is BioHarvest Sciences’s upcoming earnings report date?
BioHarvest Sciences’s upcoming earnings report date is Mar 31, 2026 which is in 3 days.
How were BioHarvest Sciences’s earnings last quarter?
BioHarvest Sciences released its earnings results on Nov 13, 2025. The company reported -$0.14 earnings per share for the quarter, missing the consensus estimate of -$0.115 by -$0.025.
Is BioHarvest Sciences overvalued?
According to Wall Street analysts BioHarvest Sciences’s price is currently Overvalued.
Does BioHarvest Sciences pay dividends?
BioHarvest Sciences does not currently pay dividends.
What is BioHarvest Sciences’s EPS estimate?
BioHarvest Sciences’s EPS estimate is -0.11.
How many shares outstanding does BioHarvest Sciences have?
BioHarvest Sciences has 22,654,290 shares outstanding.
What happened to BioHarvest Sciences’s price movement after its last earnings report?
BioHarvest Sciences reported an EPS of -$0.14 in its last earnings report, missing expectations of -$0.115. Following the earnings report the stock price went down -0.959%.
Which hedge fund is a major shareholder of BioHarvest Sciences?
Currently, no hedge funds are holding shares in BHST
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
BioHarvest Sciences Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (-11.35% Downside)
$10.00 (-11.35% Downside)
Blogger Sentiment
Neutral
BHST Sentiment 50%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.22%
12-Months-Change
Fundamentals
Return on Equity
-1198.89%
Trailing 12-Months
Asset Growth
36.27%
Trailing 12-Months
Company Description
BioHarvest Sciences
BioHarvest Sciences (BHST) is a biotechnology company specializing in the development and commercialization of innovative plant-based products for the health and wellness sectors. The company leverages its proprietary technology to produce high-quality, bioavailable compounds from various plants, targeting markets such as dietary supplements, nutraceuticals, and functional foods. With a focus on sustainability and scalability, BioHarvest aims to meet the growing consumer demand for natural health solutions.
BHST Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth, particularly in the CDMO segment, and successful capital raising efforts that fortified the company's balance sheet. However, challenges remain with ongoing net losses and increased operating expenses. The sentiment is balanced due to significant achievements and challenges.View all BHST earnings summariesBHST Stock 12 Month Forecast
Average Price Target
$10.00
▼(-11.35% Downside)
Technical Analysis
Ownership Overview
0.08% Insiders
0.05% Mutual Funds
6.30% Other Institutional Investors
93.51% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---